Aphria | Jotup

Celebrating Five Years of Growth: Tilray Brands Reflects on Industry Leadership in Canadian Cannabis and Looks Forward to its Future

Retrieved on:

Thursday, October 19, 2023

CPG, Government, Acquisition, Growth, Oil, TLRY, THC, Drink, TSX, Drug, Aphria, Q-Symbio, Tilray, Electronic cigarette

TORONTO, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, is celebrating five years of remarkable growth and industry leadership in the Canadian cannabis market since legalization.

Key Points:

TORONTO, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, is celebrating five years of remarkable growth and industry leadership in the Canadian cannabis market since legalization.
Over the past half-decade, Tilray has emerged as the most robust and leading international cannabis Licensed Producer (LP) in Canada with a cannabis market share of approximately 13.4%, inclusive of recent strategic acquisitions of HEXO Corp .
This consumer-centric approach has been the cornerstone of our innovation and success, guiding every decision we make and driving our continuous growth.
Tilray Brands’ comprehensive Canadian cannabis portfolio includes:

Tilray Brands Reports Second Quarter Fiscal Year 2023 Financial Results

Retrieved on:

Monday, January 9, 2023

All financial information in this press release is reported in U.S. dollars, unless otherwise indicated.

Key Points:

All financial information in this press release is reported in U.S. dollars, unless otherwise indicated.
Beverage-alcohol sales increased 56% to $21.4 million, over the prior year quarter, including revenue from acquisitions.
Adjusted gross margin held at 29% compared to the year ago quarter.
Irwin D. Simon, Tilray Brands’ Chairman and Chief Executive Officer, stated, “During the second quarter, Tilray Brands took decisive, effective actions to manage operating cash flow and focus the business on accretive acquisitions and a path to long term profitability.

Thailand Legal Cannabis Market Size, Share & Trends Analysis Report 2022-2030: Legalization has Opened New Revenue-Generating Opportunities for Various Industries - ResearchAndMarkets.com

Retrieved on:

Thursday, December 22, 2022

The "Thailand Legal Cannabis Market Size, Share & Trends Analysis Report by Derivative (Marijuana, Hemp), by Sources (CBD, THC), by End-use (Medical Use, Recreational Use, Industrial Use), and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points:

The "Thailand Legal Cannabis Market Size, Share & Trends Analysis Report by Derivative (Marijuana, Hemp), by Sources (CBD, THC), by End-use (Medical Use, Recreational Use, Industrial Use), and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
Cannabis legalization has opened new revenue-generating opportunities for various industries in the country.
Various studies have shown positive outcomes of marijuana and its derivatives to treat symptoms of several chronic conditions.
Growing adoption of CBD by various industries such as wellness and cosmetics, food and beverages, and others are projected to boost the segment's growth

The Constant of the Cannabis Market Generates Need for Intoxication Detection Devices

Retrieved on:

Monday, November 7, 2022

NEW YORK, Nov. 7, 2022 /PRNewswire/ -- Presently, the medical cannabis sector accounts for a majority of the market share, as progress is slowly being made in removing the stigmas associated with such products. Overall, the legal cannabis market is permeating throughout the U.S. states and is helping to create a multi-billion-dollar industry. While medical cannabis still dominates that broad cannabis marketplace, the growing awareness and legalization efforts are expected to further propel the overall industry forward. In 2020, legal cannabis sales in the U.S were up 46% from 2019, reaching a new record of USD 17.5 Billion, according to cannabinoid market research firm BDSA. Cannabix Technologies Inc. (OTC: BLOZF) (CSE: BLO), SNDL Inc. (NASDAQ: SNDL), Tilray Brands, Inc. (NASDAQ: TLRY), Cronos Group Inc. (NASDAQ: CRON), Aurora Cannabis Inc. (NASDAQ: ACB)

Key Points:

Overall, the legal cannabis market is permeating throughout the U.S. states and is helping to create a multi-billion-dollar industry.
While medical cannabis still dominates that broad cannabis marketplace, the growing awareness and legalization efforts are expected to further propel the overall industry forward.
The Company's proprietary breath capture and laboratory-based marijuana detection equipment (as described below) will be used to collect and confirm THC in breath samples.
The Cannabix BCU can be used to collect time of stop breath samples immediately upon suspicion of cannabis use by a driver.

The Constant of the Cannabis Market Generates Need for Intoxication Detection Devices

Retrieved on:

Monday, November 7, 2022

NEW YORK, Nov. 7, 2022 /PRNewswire/ -- Presently, the medical cannabis sector accounts for a majority of the market share, as progress is slowly being made in removing the stigmas associated with such products. Overall, the legal cannabis market is permeating throughout the U.S. states and is helping to create a multi-billion-dollar industry. While medical cannabis still dominates that broad cannabis marketplace, the growing awareness and legalization efforts are expected to further propel the overall industry forward. In 2020, legal cannabis sales in the U.S were up 46% from 2019, reaching a new record of USD 17.5 Billion, according to cannabinoid market research firm BDSA. Cannabix Technologies Inc. (OTC: BLOZF) (CSE: BLO), SNDL Inc. (NASDAQ: SNDL), Tilray Brands, Inc. (NASDAQ: TLRY), Cronos Group Inc. (NASDAQ: CRON), Aurora Cannabis Inc. (NASDAQ: ACB)

Key Points:

Overall, the legal cannabis market is permeating throughout the U.S. states and is helping to create a multi-billion-dollar industry.
While medical cannabis still dominates that broad cannabis marketplace, the growing awareness and legalization efforts are expected to further propel the overall industry forward.
The Company's proprietary breath capture and laboratory-based marijuana detection equipment (as described below) will be used to collect and confirm THC in breath samples.
The Cannabix BCU can be used to collect time of stop breath samples immediately upon suspicion of cannabis use by a driver.

The Continued Legalization of Cannabis Creates Need for Intoxication Detection Devices

Retrieved on:

Tuesday, October 11, 2022

NEW YORK, Oct. 11, 2022 /PRNewswire/ -- Sales of Cannabis products are expected to continue to grow as more states and major markets ease accessibility. According to data published by MJBizDaily, the combined U.S. medical and recreational cannabis sales could reach USD 33 billion by the end of 2022, mainly driven by the opening of new adult-use markets. Overall, retail cannabis sales are projected to cross the USD 52 billion mark by 2026. The data also indicates that both medical and adult-use markets posted strong growth in 2021, up an estimated 34% and 43%, respectively, over 2020 sales. The outlook for the adult-use segment of the U.S. cannabis market is even stronger in the years to come as various states with the potential for massive markets, such as New York, are in the process of working out the final details to launch programs that have been approved. Cannabix Technologies Inc. (OTC: BLOZF) (CSE: BLO), Tilray Brands, Inc. (NASDAQ: TLRY), Canopy Growth Corporation (NASDAQ: CGC), Cronos Group Inc. (NASDAQ: CRON), Aurora Cannabis Inc. (NASDAQ: ACB)

Key Points:

Overall, retail cannabis sales are projected to cross the USD 52 billion mark by 2026.
Cannabix Technologies Inc. (OTC: BLOZF) (CSE: BLO), Tilray Brands, Inc. (NASDAQ: TLRY), Canopy Growth Corporation (NASDAQ: CGC), Cronos Group Inc. (NASDAQ: CRON), Aurora Cannabis Inc. (NASDAQ: ACB)
While cannabis legalization is expanding so does the need for better regulations.
Cannabix has participated in two testing day events held in two different US cities in June and July.
Our new CannaPoints program serves to guide our patients on their medical cannabis journey and provide additional support as needed."

The Continued Legalization of Cannabis Creates Need for Intoxication Detection Devices

Retrieved on:

Tuesday, October 11, 2022

NEW YORK, Oct. 11, 2022 /PRNewswire/ -- Sales of Cannabis products are expected to continue to grow as more states and major markets ease accessibility. According to data published by MJBizDaily, the combined U.S. medical and recreational cannabis sales could reach USD 33 billion by the end of 2022, mainly driven by the opening of new adult-use markets. Overall, retail cannabis sales are projected to cross the USD 52 billion mark by 2026. The data also indicates that both medical and adult-use markets posted strong growth in 2021, up an estimated 34% and 43%, respectively, over 2020 sales. The outlook for the adult-use segment of the U.S. cannabis market is even stronger in the years to come as various states with the potential for massive markets, such as New York, are in the process of working out the final details to launch programs that have been approved. Cannabix Technologies Inc. (OTC: BLOZF) (CSE: BLO), Tilray Brands, Inc. (NASDAQ: TLRY), Canopy Growth Corporation (NASDAQ: CGC), Cronos Group Inc. (NASDAQ: CRON), Aurora Cannabis Inc. (NASDAQ: ACB)

Key Points:

Overall, retail cannabis sales are projected to cross the USD 52 billion mark by 2026.
Cannabix Technologies Inc. (OTC: BLOZF) (CSE: BLO), Tilray Brands, Inc. (NASDAQ: TLRY), Canopy Growth Corporation (NASDAQ: CGC), Cronos Group Inc. (NASDAQ: CRON), Aurora Cannabis Inc. (NASDAQ: ACB)
While cannabis legalization is expanding so does the need for better regulations.
Cannabix has participated in two testing day events held in two different US cities in June and July.
Our new CannaPoints program serves to guide our patients on their medical cannabis journey and provide additional support as needed."

Hemp Company Starts Selling Hemp Cigarettes Branded After Famous Comedy Duo

Retrieved on:

Tuesday, October 4, 2022

NEW YORK, Oct. 4, 2022 /PRNewswire/ -- Hempacco, a vertically integrated hemp manufacturing company, began selling Cheech & Chong branded hemp smoking products in the third quarter of 2022 as part of its joint venture 50/50 previously announced. In January 2022, Hempacco entered into a joint venture agreement with Cheech and Chong's Cannabis Company (CCCC). Hempacco launched its first line of Cheech & Chong-branded hemp smoking products and hemp packaging, as well as a Cheech & Chong-branded kiosk vending machine, with Tommy Chong, at the Tobacco Plus Expo in Las Vegas in January. Of course, Hempacco Co., Inc. (NASDAQ:HPCO) isn't the only company providing new products to the market. The Hempshire Group (TSXV:HMPG) (OTCPK:HMPSF), MariMed, Inc (CSE:MRMD) (OTCQX:MRMD), MedMen Enterprises Inc. (CSE:MMEN) (OTCQX:MMNFF), and Tilray Brands Inc (TSX:TLRY) (NASDAQ:TLRY) also expanding their product lines.

Key Points:

NEW YORK, Oct. 4, 2022 /PRNewswire/ -- Hempacco, a vertically integrated hemp manufacturing company, began selling Cheech & Chong branded hemp smoking products in the third quarter of 2022 as part of its joint venture 50/50 previously announced.
In January 2022, Hempacco entered into a joint venture agreement with Cheech and Chong's Cannabis Company (CCCC).
The Hempshire Group (TSXV:HMPG) (OTC:HMPSF)is a California-based smokable alternatives company formulating and selling its own proprietary brand of organic hemp smokes under the MOUNTAIN Smokes brand name.
Hemp smokables company Hempacco Co., Inc. (NASDAQ:HPCO) has continued expanding its reach in the market.

Hemp Company Starts Selling Hemp Cigarettes Branded After Famous Comedy Duo

Retrieved on:

Tuesday, October 4, 2022

NEW YORK, Oct. 4, 2022 /PRNewswire/ -- Hempacco, a vertically integrated hemp manufacturing company, began selling Cheech & Chong branded hemp smoking products in the third quarter of 2022 as part of its joint venture 50/50 previously announced. In January 2022, Hempacco entered into a joint venture agreement with Cheech and Chong's Cannabis Company (CCCC). Hempacco launched its first line of Cheech & Chong-branded hemp smoking products and hemp packaging, as well as a Cheech & Chong-branded kiosk vending machine, with Tommy Chong, at the Tobacco Plus Expo in Las Vegas in January. Of course, Hempacco Co., Inc. (NASDAQ:HPCO) isn't the only company providing new products to the market. The Hempshire Group (TSXV:HMPG) (OTCPK:HMPSF), MariMed, Inc (CSE:MRMD) (OTCQX:MRMD), MedMen Enterprises Inc. (CSE:MMEN) (OTCQX:MMNFF), and Tilray Brands Inc (TSX:TLRY) (NASDAQ:TLRY) also expanding their product lines.

Key Points:

NEW YORK, Oct. 4, 2022 /PRNewswire/ -- Hempacco, a vertically integrated hemp manufacturing company, began selling Cheech & Chong branded hemp smoking products in the third quarter of 2022 as part of its joint venture 50/50 previously announced.
In January 2022, Hempacco entered into a joint venture agreement with Cheech and Chong's Cannabis Company (CCCC).
The Hempshire Group (TSXV:HMPG) (OTC:HMPSF)is a California-based smokable alternatives company formulating and selling its own proprietary brand of organic hemp smokes under the MOUNTAIN Smokes brand name.
Hemp smokables company Hempacco Co., Inc. (NASDAQ:HPCO) has continued expanding its reach in the market.

A Market Leader Expands With Innovative CBD Gummy Line

Retrieved on:

Thursday, September 15, 2022

NEW YORK, Sept. 15, 2022 /PRNewswire/ -- NuLeaf Naturals, one of America's top pioneering cannabinoid companies, has launched a new CBD gummies line. Desperate for a good night's rest, more consumers are turning to CBD and CBN gummies for their sleep issues, especially as natural wellness trends have increased since the pandemic. Various cannabinoid products are available from the well-known industry developer and manufacturer of organic cannabinoid products in the form of oils (for humans and animals) and herbal capsules. To meet the growing consumer demand, cannabis companies Hempshire Group (TSXV:HMPG) (OTCPK:HMPSF), HEXO Corp (TSX:HEXO) (NASDAQ:HEXO), Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC), Tilray Brands Inc (TSX:TLRY) (NASDAQ:TLRY), and Aurora Cannabis (NASDAQ:ACB) (TSX:ACB) are also expanding their CBD products line.

Key Points:

NEW YORK, Sept. 15, 2022 /PRNewswire/ -- NuLeaf Naturals, one of America's top pioneering cannabinoid companies, has launched a new CBD gummies line.
"Penetrating the US$261 billion tobacco products market in Europe is one of our top priorities."
The business created by Hoist and Hempshire U.S. union is well-positioned to dominate the market for tobacco- and nicotine-free smoking alternatives.
On August 15, Martha Stewart CBD's line of CBD gummies unveiled a new flavour - Pumpkin Spice CBD Wellness Gummies.